<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are at increased risk of acquiring <z:e sem="disease" ids="C0025229" disease_type="Disease or Syndrome" abbrv="">melioidosis</z:e>, a disease caused by Burkholderia pseudomallei <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although up to half of <z:e sem="disease" ids="C0025229" disease_type="Disease or Syndrome" abbrv="">melioidosis</z:e> patients have underlying <z:mp ids='MP_0002055'>diabetes</z:mp>, the mechanisms involved in this increased susceptibility are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We found that B. pseudomallei-infected PBMCs from diabetic patients were impaired in IL-12p70 production, which resulted in decreased IFN-γ induction and poor <z:mp ids='MP_0001794'>bacterial</z:mp> killing </plain></SENT>
<SENT sid="3" pm="."><plain>The defect was specific to the IL-12-IFN-γ axis </plain></SENT>
<SENT sid="4" pm="."><plain>Defective IL-12 production was also observed during <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">Mycobacterium tuberculosis infection</z:e>, in which <z:mp ids='MP_0002055'>diabetes</z:mp> is likewise known to be a strong risk factor </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, IL-12 production in diabetic cells was not affected upon Salmonella enterica <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or in response to TLR2, -3, -4, and -5 ligands </plain></SENT>
<SENT sid="6" pm="."><plain>Poor IL-12 production correlated with a deficiency in intracellular reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) concentrations in diabetic patients </plain></SENT>
<SENT sid="7" pm="."><plain>Addition of GSH or <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi> to PBMCs selectively restored IL-12 and IFN-γ production and improved <z:mp ids='MP_0001794'>bacterial</z:mp> killing </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, the <z:mpath ids='MPATH_63'>depletion</z:mpath> of GSH in mice led to increased susceptibility to <z:e sem="disease" ids="C0025229" disease_type="Disease or Syndrome" abbrv="">melioidosis</z:e>, reduced production of IL-12p70, and poorer disease outcome </plain></SENT>
<SENT sid="9" pm="."><plain>Our data thus establish a link between GSH deficiency in <z:mp ids='MP_0002055'>diabetes</z:mp> and increased susceptibility to <z:e sem="disease" ids="C0025229" disease_type="Disease or Syndrome" abbrv="">melioidosis</z:e> that may open up new therapeutic avenues to protect diabetic patients against some intracellular <z:mp ids='MP_0001794'>bacterial</z:mp> pathogens </plain></SENT>
</text></document>